Prognostic significance of serum thymidine phosphorylase concentration in esophageal squamous cell carcinoma

Cancer

Volumn 94, Issue 7, 2002, Pages 1947-1954

  Shimada, Hideaki ^a   Takeda, Akihiko ^a   Shiratori, Tooru ^a   Nabeya, Yoshihiro ^a   Okazumi, Shin Ichi ^a   Matsubara, Hisahiro ^a   Funami, Yutaka ^a   Hayashi, Hideki ^a   Gunji, Yoshio ^a   Kobayashi, Susumu ^a   Suzuki, Takao ^a   Ochiai, Takenori ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Chemoradiotherapy; Esophageal carcinoma; Immunohistochemistry; Prognosis; Serum thymidine phosphorylase

Indexed keywords

CISPLATIN; FLUOROURACIL; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE PHOSPHORYLASE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INDUCING AGENTS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; THYMIDINE PHOSPHORYLASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0036534319     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10418     Document Type: Article

References (26)

1. National cancer database report on esophageal carcinoma
2. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma
3. Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma
4. Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas
5. Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus
6. Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumor growth and response to therapy
7. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer
8. The activity and expression of thymidine phosphorylase in human solid tumors
9. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma
10. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma
11. Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tissues
12. Thymidine phosphorylase in human esophageal squamous cell carcinoma
13. The prognostic significance of micro vessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus
14. Circulating plateletderived endothelial cell growth factor increases in hepatocellular carcinoma patients
15. The value of platelet-derived endothelial cell growth factor as a novel predictor of advancement of uterine cervical cancers
16. Parameters linked to ten-year survival in Japan of resected esophageal carcinoma
17. Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissue
18. Expression of platelet-derived endothelial cell growth factor in oral and oropharyngeal carcinoma
19. High basal level gene expression of thymidine phosphorylase (plateletderived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil
20. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation
21. Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer
22. Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in human colorectal cancer
23. Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis
24. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in turnouts by enzymes concentrated in human liver and cancer tissue
25. Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts